Viewing nowCombinationTwinx Tablet 80/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Youngpung Pharmaceutical Co., Ltd.

MFDS item code 201706788 · Approved 2017.08.23 · Insurance code 661904820
Treatment of essential hypertension not controlled by monotherapy
This medication helps effectively lower blood pressure when patients with essential hypertension do not have sufficient control with amlodipine or telmisartan monotherapy. It contributes to stable blood pressure management and reduces the risk of cardiovascular complications. The drug is effective in controlling blood pressure by dilating blood vessels and blocking the actions of substances that raise blood pressure. It plays a crucial role in maintaining the patient's blood pressure at a stable level to protect their health. Therefore, the combination therapy of amlodipine and telmisartan improves hypertension management.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.
This medication may pose serious risks to the fetus, especially in the second and third trimesters, therefore pregnant women or women who may become pregnant should not take this medication. The drug is contraindicated in patients with certain conditions, such as those with severe impairment of heart or liver function, hypotensive patients, those with specific heart valve diseases, and patients with severely reduced diabetes or kidney function. Caution is required when administering this medication to patients with primary aldosteronism, liver disease, gastrointestinal diseases, renal artery hypertension, etc., and special care is needed for the elderly. The most common side effects reported while taking this medication are dizziness and peripheral edema. The use of this medication during pregnancy may lead to severe issues such as reduced renal function in the fetus, oligohydramnios, and delayed skull formation, so it should be discontinued immediately upon confirmation of pregnancy. It is also safe for breastfeeding women not to take this medication. In patients with impaired kidney function, this medication can cause elevated potassium levels in the blood, so regular blood tests are necessary. Be cautious of drug interactions when used with other medications, especially with digoxin, lithium, warfarin, and non-steroidal anti-inflammatory drugs. This drug may cause dizziness or drowsiness while driving or operating machinery, so caution is needed. In cases of overdose, symptoms such as hypotension, cardiac rhythm abnormalities, and dizziness may occur; medical attention should be sought immediately, and appropriate treatment is necessary. The safety and efficacy of this medication have not been established for use in children, and its usage is not recommended.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a container that does not allow light to enter. Additionally, it is important to maintain a room temperature, specifically between 1 to 30 degrees Celsius, during storage to preserve the drug's effectiveness for a longer duration.
White or off-white rectangular tablet
30 tablets/box [(10 tablets/Alu-Alu * 3)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Youngpung Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.